Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Antiviral therapies for the management of persistent coronavirus disease 2019 in immunocompromised hosts: A narrative review.

  • Authors : Kinsella PM; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Infectious Diseases, University of Melbourne at the Doherty Institute of Infection and Immunity, Melbourne, Australia.

Subjects: Immunocompromised Host* ; Antiviral Agents*/Antiviral Agents*/Antiviral Agents*/therapeutic use ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology

  • Source: Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2024 Jun; Vol. 26 (3), pp. e14301. Date of Electronic Publication: 2024 May Publisher: Munksgaard Country of Publication: Denmark NLM ID: 100883688 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical phenotype and outcome of persistent SARS-CoV-2 replication in immunocompromised hosts: a retrospective observational study in the Omicron era.

  • Authors : Götz V; Faculty of Medicine, Division of Infectious Diseases, Department of Medicine II, Medical Center, University of Freiburg, Hugstetter Str. 55, 79106, Freiburg, Germany. .; Mathé P

Subjects: Immunocompromised Host* ; COVID-19*/COVID-19*/COVID-19*/virology ; COVID-19*/COVID-19*/COVID-19*/diagnosis

  • Source: Infection [Infection] 2024 Jun; Vol. 52 (3), pp. 923-933. Date of Electronic Publication: 2023 Dec 14.Publisher: Springer Heidelberg Country of Publication: Germany NLM ID: 0365307 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Clinical and Imaging Characteristics of SARS-CoV-2 Breakthrough Infection in Hospitalized Immunocompromised Patients.

  • Authors : Lee JE; Department of Radiology, Chonnam National University Hospital, Gwangju, Republic of Korea.; Kim J

Subjects: COVID-19*/COVID-19*/COVID-19*/diagnostic imaging ; Immunocompromised Host* ; Tomography, X-Ray Computed*/Tomography, X-Ray Computed*/Tomography, X-Ray Computed*/methods

  • Source: Korean journal of radiology [Korean J Radiol] 2024 May; Vol. 25 (5), pp. 481-492. Date of Electronic Publication: 2024 Mar 20.Publisher: Korean Society of Radiology Country of Publication: Korea (South) NLM ID: 100956096 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Intravenous immunoglobulin therapy for COVID-19 in immunocompromised patients: A retrospective cohort study.

  • Authors : Gröning R; Department of Clinical Microbiology, Umeå University, Umeå, Sweden.; Walde J

Subjects: Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/therapeutic use ; Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/Immunoglobulins, Intravenous*/administration & dosage ; Immunocompromised Host*

  • Source: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2024 Jul; Vol. 144, pp. 107046. Date Publisher: Elsevier Country of Publication: Canada NLM ID: 9610933 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3511

Record details

×
Academic Journal

Comparative analysis of dynamic transcriptomes reveals specific COVID-19 features and pathogenesis of immunocompromised populations.

  • Authors : Yang X; Department of Hematology, Peking University First Hospital, Beijing, China.; Zhu J

Subjects: COVID-19*/COVID-19*/COVID-19*/genetics ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/virology

  • Source: MSystems [mSystems] 2024 Jun 18; Vol. 9 (6), pp. e0138523. Date of Electronic Publication: 2024 May 16.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 101680636 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study.

  • Authors : Huygens S; Department of Internal Medicine, Section of Infectious Diseases and Department of Medical Microbiology and Infectious Diseases, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.; GeurtsvanKessel C

Subjects: SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/immunology ; SARS-CoV-2*/SARS-CoV-2*/SARS-CoV-2*/genetics ; Immunocompromised Host* SARS-CoV-2 variants

  • Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jun 14; Vol. 78 (6), pp. 1514-1521.Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The Association Between Antibody Responses and Prolonged Viable Severe Acute Respiratory Syndrome Coronavirus 2 Shedding in Immunocompromised Patients: A Prospective Cohort Study.

  • Authors : Lim SY; Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul.; Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul.

Subjects: Virus Shedding* ; Immunocompromised Host* ; COVID-19*/COVID-19*/COVID-19*/immunology

  • Source: The Journal of infectious diseases [J Infect Dis] 2024 Jun 14; Vol. 229 (6), pp. 1722-1727.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Uptake, effectiveness and safety of COVID-19 vaccines in individuals at clinical risk due to immunosuppressive drug therapy or transplantation procedures: a population-based cohort study in England.

  • Authors : Chen DT; Nuffield Department of Primary Care Health Science, University of Oxford, Radcliffe Observatory Quarter, Woodstock Road, Oxford, OX2 6GG, UK.; Copland E

Subjects: COVID-19*/COVID-19*/COVID-19*/prevention & control ; COVID-19*/COVID-19*/COVID-19*/epidemiology ; COVID-19 Vaccines*/COVID-19 Vaccines*/COVID-19 Vaccines*/adverse effects

  • Source: BMC medicine [BMC Med] 2024 Jun 10; Vol. 22 (1), pp. 237. Date of Electronic Publication: 2024 Jun 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015

Record details

×
Academic Journal

Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study.

  • Authors : Rotundo S; Dipartimento di Scienze Mediche e Chirurgiche, Università 'Magna Graecia', Catanzaro, Italy. .; Berardelli L

Subjects: Immunocompromised Host* ; COVID-19*/COVID-19*/COVID-19*/immunology ; COVID-19*/COVID-19*/COVID-19*/mortality

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Jun 06; Vol. 24 (1), pp. 564. Date of Electronic Publication: 2024 Jun 06.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

×
  • 1-10 of  2,552 results for ""Immunocompromised Host""